Bank of America
SGMO

Bank of America’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bank of America’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40,000
Closed -$360K – 8593
2021
Q3 		$360K Buy
+40,000
New +$395K ﹤0.01% 5880
2021
Q2 		– Sell
-30,000
Closed -$376K – 8046
2021
Q1 		$376K Buy
+30,000
New +$404K ﹤0.01% 5595

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Bank of America's SGMO Position: Q1 2026 in Review

Bank of America increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 1,856% in Q1 2026, buying an estimated $694K and bringing the position to 1,838,390 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #4946.

Bank of America first reported a position in SGMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.62M in Q1 2014. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Bank of America held 1,838,390 shares of SANGAMO THERAPEUTICS INC worth $452K as of Q1 2026.
  • Bank of America bought 1,744,406 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $694K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4946 holding.
  • Bank of America first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's SANGAMO THERAPEUTICS INC position peaked at $6.62M in Q1 2014.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.